Antithrombotic Therapy After Percutaneous Coronary Intervention in Atrial Fibrillation

Am J Cardiol. 2020 Aug 15:129:122-124. doi: 10.1016/j.amjcard.2020.05.012. Epub 2020 May 18.

Authors

Cosmo Godino¹, Carlo Andrea Pivato², Claudia Rubino³, Anita Russi³, Michela Cera³, Alberto Margonato³

Affiliations

¹ San Raffaele Scientific Institute, Milan, Italy. Electronic address: cosmogodino@gmail.com.
² Humanitas Clinical and Research Center IRCCS, Rozzano, Italy.
³ San Raffaele Scientific Institute, Milan, Italy.

PMID: 32540165
DOI: 10.1016/j.amjcard.2020.05.012

No abstract available

Publication types

Letter

MeSH terms

Anticoagulants / therapeutic use*
Atrial Fibrillation / complications*
Coronary Artery Disease / complications
Coronary Artery Disease / surgery*
Dual Anti-Platelet Therapy / adverse effects
Dual Anti-Platelet Therapy / methods*
Europe
Hemorrhage / chemically induced*
Humans
Percutaneous Coronary Intervention*
Platelet Aggregation Inhibitors / therapeutic use*
Postoperative Care / methods
Practice Guidelines as Topic
Purinergic P2Y Receptor Antagonists / therapeutic use*
Randomized Controlled Trials as Topic
Stents
United States

Substances

Anticoagulants
Platelet Aggregation Inhibitors
Purinergic P2Y Receptor Antagonists